The stock market appears to be at a turning point. While major indexes are still hovering near record levels, there’s been ...

We recently compiled a list of the 14 Worst 52-Week High Stocks to Buy According to Short Sellers. In this article, we are ...

FedEx Corp. (FDX) is facing increasing pressure as its latest earnings report revealed a significant miss on both profit and ...

"Should September's positive returns hold as we expect, it would mark the fourth consecutive month of positive total returns ...

Each of the Morgan Stanley closed-end funds listed below (the “Funds”) today declared the following dividends. RECORD DATE PAYABLE DATE 9/30/24 10/15/ ...

BENGALURU, (REUTERS) – India has overtaken China for the first time ever in a key MSCI equities index, bolstered by steady ...

Associates say a failed attempt to buy the Buffalo Bills in 2014 cleared a path for him to run for office and gave him a grudge against the league.

The SEC asked a federal judge to sanction Elon Musk if he continues to delay a deposition regarding his 2022 Twitter buyout.

One pundit tracking the company is particularly concerned about the performance of its foundational snacks business.

A significant shareholding is being unloaded to the public.

Morgan Stanley's fee-based revenue structure and AI integration position them to thrive in a lower interest rate environment.

Crinetics Pharmaceuticals Inc (CRNX) stock saw a modest uptick, ending the day at $53.88 which represents a slight increase of $1.11 or 2.10% from the prior close of $52.77. The stock opened at $54.02 ...